Mira Pharmaceuticals (MIRA) Interest Expenses (2022 - 2025)

Mira Pharmaceuticals has reported Interest Expenses for 4 years, with the latest figure at $21656.0 in Q4 2025.

• Quarterly Interest Expenses fell 83.68% year-over-year to $21656.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12676.0 (down 99.64% YoY) and the FY2025 annual result came in at $9.6 million, up 38.47% from the prior year.
• Interest Expenses improved to $21656.0 in Q4 2025 per MIRA's latest filing, from $12441.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $3.5 million in Q4 2023 and troughed at -$89812.0 in Q2 2024.
• A 4-year average of $542028.4 and a median of $12441.0 in 2025 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2023 and 2024: Interest Expenses soared 196774.8% in 2023, then slumped 130.35% in 2024.
• Over 4 years, Interest Expenses stood at $1766.0 in 2022, then jumped by 196774.8% to $3.5 million in 2023, then sank by 96.18% to $132656.0 in 2024, then sank by 83.68% to $21656.0 in 2025.
• According to Business Quant data, Interest Expenses over the past three periods registered $21656.0, $12441.0, and -$21421.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.